GWG Holdings’ Insurtech Subsidiary, Life Epigenetics, Announces Two Major Insurers to Test Lifespan-Predictive Technology

Life Epigenetics, the insurtech subsidiary of GWG Holdings, Inc. (Nasdaq:GWGH), announced that two major life insurance companies will begin pilot programs to test its epigenetic-based M-Panel technology.